STOCKHOLM, SWEDEN, Tuesday, June 22, 2010 – Diamyd Medical AB has signed an agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company, to develop and commercialize the Diamyd® diabetes therapy, The agreement relates to the development and world-wide commercialization of the GAD65 antigen-based therapy (Diamyd®) for the treatment and prevention of type 1 diabetes and associated conditions.
Kraft Foods And Medisyn Technologies Expand Collaboration To Discover New Ingredients
NORTHFIELD, IL & MINNEAPOLIS, MN, May 18, 2010 – Kraft Foods and Medisyn Technologies, Inc., have expanded their collaboration to discover novel ingredients that could provide benefits for product quality, performance, food safety and health and wellness.
MediCalculate Introduced By Destum Partners To Help Negotiate Transactions
Charlotte, NC (June, 2009) Destum Partners is pleased to introduce the launch of their second market analytics product focused on providing companies with quantitative terms to help negotiate licensing terms. MediCalculate was developed over years of business development experience, and was a tool used internally to help our clients negotiate licensing transactions.